Comparision of effectiveness between two local anaesthetic drugs in Subarachnoid block for surgeries below the level of Umblicus.

A Comparative study to evaluate the clinical efficacy of Subarachnoid block using Hyperbaric Levobupivacine 0.5% Versus Hyperbaric Ropivacaine 0.75% for elective infraumblical surgeries

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067647

Enrollment

Registered

2024-05-20

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Inj. Levobupivacaine: 3ml of 0.5% Inj.Hyperbaric Levobupivacaine given intrathecally for elective infraumblical surgeries and monitored for 2 hours Control Intervention1: Inj. Ropivacai

Eligibility

Inclusion criteria

Inclusion criteria: -Patient wiiling to give written informed consent -Patients belonging to American Society of Anaesthesiologist physical status class 1 and 2 of either sex. - Patient with age group between 18 to 65 years posted for elective infraumblical surgeries.

Exclusion criteria

Exclusion criteria: 1.Patients with coagulation disorders or on anticoagulants. 2.Any other contraindications for spinal anaesthesia. 3.Patients with spinal deformity,infection at the site of the procedure.

Design outcomes

Primary

Measure	Time frame
To evaluate and compare the onset of sensory and motor block characteristics and duration of sensory and motor block among the two study drugsTimepoint: 2 hours	—

Secondary

Measure	Time frame
To study hemodynamic characteristics between the two drugs To assess the complications/side effects among the drugs.Timepoint: 2 hours	—

Countries

India

Contacts

Public ContactDr Harshini

Chamarajanagar Institute of Medical Sciences

darshanms_jss@yahoo.com9741376797

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026